This report contains market size and forecasts of Active Pharmaceutical Ingredient (API) in global, including the following market information:
Global Active Pharmaceutical Ingredient (API) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Active Pharmaceutical Ingredient (API) Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Active Pharmaceutical Ingredient (API) companies in 2020 (%)
The global Active Pharmaceutical Ingredient (API) market was valued at 65040 million in 2020 and is projected to reach US$ 83030 million by 2027, at a CAGR of 6.3% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Pharmaceutical Ingredient (API) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Pharmaceutical Ingredient (API) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Active Pharmaceutical Ingredient (API) Market Segment Percentages, By Type, 2020 (%)
Anti-Infective
Hormonal
Others
Global Active Pharmaceutical Ingredient (API) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Active Pharmaceutical Ingredient (API) Market Segment Percentages, By Application, 2020 (%)
Respiratory
Rheumatology
Diabetes
Oncology
Others
Global Active Pharmaceutical Ingredient (API) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Active Pharmaceutical Ingredient (API) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Pharmaceutical Ingredient (API) revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Active Pharmaceutical Ingredient (API) revenues share in global market, 2020 (%)
Key companies Active Pharmaceutical Ingredient (API) sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Active Pharmaceutical Ingredient (API) sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy's Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Active Pharmaceutical Ingredient (API) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Pharmaceutical Ingredient (API) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Pharmaceutical Ingredient (API) Overall Market Size
2.1 Global Active Pharmaceutical Ingredient (API) Market Size: 2021 VS 2027
2.2 Global Active Pharmaceutical Ingredient (API) Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Active Pharmaceutical Ingredient (API) Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Active Pharmaceutical Ingredient (API) Players in Global Market
3.2 Top Global Active Pharmaceutical Ingredient (API) Companies Ranked by Revenue
3.3 Global Active Pharmaceutical Ingredient (API) Revenue by Companies
3.4 Global Active Pharmaceutical Ingredient (API) Sales by Companies
3.5 Global Active Pharmaceutical Ingredient (API) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Active Pharmaceutical Ingredient (API) Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Active Pharmaceutical Ingredient (API) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Pharmaceutical Ingredient (API) Players in Global Market
3.8.1 List of Global Tier 1 Active Pharmaceutical Ingredient (API) Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredient (API) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Active Pharmaceutical Ingredient (API) Market Size Markets, 2021 & 2027
4.1.2 Anti-Infective
4.1.3 Hormonal
4.1.4 Others
4.2 By Type - Global Active Pharmaceutical Ingredient (API) Revenue & Forecasts
4.2.1 By Type - Global Active Pharmaceutical Ingredient (API) Revenue, 2016-2021
4.2.2 By Type - Global Active Pharmaceutical Ingredient (API) Revenue, 2022-2027
4.2.3 By Type - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2016-2027
4.3 By Type - Global Active Pharmaceutical Ingredient (API) Sales & Forecasts
4.3.1 By Type - Global Active Pharmaceutical Ingredient (API) Sales, 2016-2021
4.3.2 By Type - Global Active Pharmaceutical Ingredient (API) Sales, 2022-2027
4.3.3 By Type - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2016-2027
4.4 By Type - Global Active Pharmaceutical Ingredient (API) Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Active Pharmaceutical Ingredient (API) Market Size, 2021 & 2027
5.1.2 Respiratory
5.1.3 Rheumatology
5.1.4 Diabetes
5.1.5 Oncology
5.1.6 Others
5.2 By Application - Global Active Pharmaceutical Ingredient (API) Revenue & Forecasts
5.2.1 By Application - Global Active Pharmaceutical Ingredient (API) Revenue, 2016-2021
5.2.2 By Application - Global Active Pharmaceutical Ingredient (API) Revenue, 2022-2027
5.2.3 By Application - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2016-2027
5.3 By Application - Global Active Pharmaceutical Ingredient (API) Sales & Forecasts
5.3.1 By Application - Global Active Pharmaceutical Ingredient (API) Sales, 2016-2021
5.3.2 By Application - Global Active Pharmaceutical Ingredient (API) Sales, 2022-2027
5.3.3 By Application - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2016-2027
5.4 By Application - Global Active Pharmaceutical Ingredient (API) Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Active Pharmaceutical Ingredient (API) Market Size, 2021 & 2027
6.2 By Region - Global Active Pharmaceutical Ingredient (API) Revenue & Forecasts
6.2.1 By Region - Global Active Pharmaceutical Ingredient (API) Revenue, 2016-2021
6.2.2 By Region - Global Active Pharmaceutical Ingredient (API) Revenue, 2022-2027
6.2.3 By Region - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2016-2027
6.3 By Region - Global Active Pharmaceutical Ingredient (API) Sales & Forecasts
6.3.1 By Region - Global Active Pharmaceutical Ingredient (API) Sales, 2016-2021
6.3.2 By Region - Global Active Pharmaceutical Ingredient (API) Sales, 2022-2027
6.3.3 By Region - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Active Pharmaceutical Ingredient (API) Revenue, 2016-2027
6.4.2 By Country - North America Active Pharmaceutical Ingredient (API) Sales, 2016-2027
6.4.3 US Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.4.4 Canada Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.4.5 Mexico Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Active Pharmaceutical Ingredient (API) Revenue, 2016-2027
6.5.2 By Country - Europe Active Pharmaceutical Ingredient (API) Sales, 2016-2027
6.5.3 Germany Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.5.4 France Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.5.5 U.K. Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.5.6 Italy Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.5.7 Russia Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.5.8 Nordic Countries Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.5.9 Benelux Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Active Pharmaceutical Ingredient (API) Revenue, 2016-2027
6.6.2 By Region - Asia Active Pharmaceutical Ingredient (API) Sales, 2016-2027
6.6.3 China Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.6.4 Japan Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.6.5 South Korea Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.6.6 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.6.7 India Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Active Pharmaceutical Ingredient (API) Revenue, 2016-2027
6.7.2 By Country - South America Active Pharmaceutical Ingredient (API) Sales, 2016-2027
6.7.3 Brazil Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.7.4 Argentina Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Sales, 2016-2027
6.8.3 Turkey Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.8.4 Israel Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.8.5 Saudi Arabia Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
6.8.6 UAE Active Pharmaceutical Ingredient (API) Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Active Pharmaceutical Ingredient (API) Major Product Offerings
7.1.4 Teva Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.1.5 Teva Key News
7.2 Mylan
7.2.1 Mylan Corporate Summary
7.2.2 Mylan Business Overview
7.2.3 Mylan Active Pharmaceutical Ingredient (API) Major Product Offerings
7.2.4 Mylan Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.2.5 Mylan Key News
7.3 DSM
7.3.1 DSM Corporate Summary
7.3.2 DSM Business Overview
7.3.3 DSM Active Pharmaceutical Ingredient (API) Major Product Offerings
7.3.4 DSM Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.3.5 DSM Key News
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Corporate Summary
7.4.2 Aurobindo Pharma Business Overview
7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Major Product Offerings
7.4.4 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.4.5 Aurobindo Pharma Key News
7.5 Aspen
7.5.1 Aspen Corporate Summary
7.5.2 Aspen Business Overview
7.5.3 Aspen Active Pharmaceutical Ingredient (API) Major Product Offerings
7.5.4 Aspen Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.5.5 Aspen Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Active Pharmaceutical Ingredient (API) Major Product Offerings
7.6.4 Novartis Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.6.5 Novartis Key News
7.7 BASF
7.7.1 BASF Corporate Summary
7.7.2 BASF Business Overview
7.7.3 BASF Active Pharmaceutical Ingredient (API) Major Product Offerings
7.4.4 BASF Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.7.5 BASF Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Active Pharmaceutical Ingredient (API) Major Product Offerings
7.8.4 Pfizer Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.8.5 Pfizer Key News
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Corporate Summary
7.9.2 Huahai Pharmaceutical Business Overview
7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Major Product Offerings
7.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.9.5 Huahai Pharmaceutical Key News
7.10 Hisun Pharmaceutical
7.10.1 Hisun Pharmaceutical Corporate Summary
7.10.2 Hisun Pharmaceutical Business Overview
7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Major Product Offerings
7.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.10.5 Hisun Pharmaceutical Key News
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Corporate Summary
7.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Business Overview
7.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.11.5 Sun Pharmaceutical Industries Key News
7.12 Zhejiang Medicine
7.12.1 Zhejiang Medicine Corporate Summary
7.12.2 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Business Overview
7.12.3 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Major Product Offerings
7.12.4 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2016-2021)
7.12.5 Zhejiang Medicine Key News
7.13 Dr. Reddy